Stock 6541 TANVEX BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Tanvex BioPharma, Inc.

Equities

6541

KYG8676P1037

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
45.6 TWD +0.11% Intraday chart for Tanvex BioPharma, Inc. -5.00% -29.95%
Mar. 14 Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 06 Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer
CI
Tanvex BioPharma, Inc. Announces the Appointment of Chen, Lin-Cheng as CEO
CI
Tanvex Biologics Corporation announced that it expects to receive $5 million in funding from Tanvex BioPharma, Inc.
CI
Tanvex BioPharma USA, Inc. announced that it expects to receive $50 million in funding from Tanvex BioPharma, Inc.
CI
Tanvex BioPharma, Inc. Announces the Resignation of Ken Huang as Accounting Officer
CI
Tanvex BioPharma, Inc. Announces Change of Chairman
CI
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen Chairperson and Director, Effective December 29, 2023
CI
Tanvex BioPharma, Inc. Announces Change of Corporate Governance Officer
CI
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen as CEO, Effective December 29, 2023
CI
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen as Chairman/President, Effective December 29, 2023
CI
Tanvex BioPharma, Inc. Announces the Resignation of Stacey Tsai as Acting Spokesperson and Corporate Governance Officer
CI
Tanvex BioPharma, Inc. Appoints Wen Chung Yeh as Chief Financial Officer
CI
Tanvex BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Tanvex BioPharma, Inc. Announces Management Changes
CI
Tanvex BioPharma, Inc.(TWSE:6541) added to S&P Global BMI Index
CI
Tanvex BioPharma, Inc.(TWSE:6541) added to Taiwan TAIEX Index
CI
Tanvex BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Tanvex BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tanvex BioPharma, Inc.(TWSE:6541) dropped from Taiwan TAIEX Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6541 Stock
  4. News Tanvex BioPharma, Inc.